Literature DB >> 32952350

Delayed Coronary Obstruction after Transcatheter Aortic Valve Replacement - An Uncommon But Serious Complication.

Wei-Hsian Yin1,2, Yung-Tsai Lee1,3, Tien-Ping Tsao1,4, Jeng Wei1,4.   

Abstract

As transcatheter aortic valve replacement (TAVR) becomes the mainstream treatment for valvular aortic stenosis, it is vitally important to recognize its associated procedural complications. Among the clinically relevant but uncommonly seen complications, the development of delayed coronary obstruction (DCO) occurring during the early post-procedural phase or even later following the index TAVR procedure, has been reported. These reports have raised concerns as TAVR comes more common in lower-risk patients. In this review article, we explored the implications of DCO for pre-procedural computed tomography evaluation, valve selection and sizing, intra-procedural manipulation, and approaches to post-procedural management.

Entities:  

Keywords:  Complication; Delayed coronary obstruction; Transcatheter aortic valve replacement

Year:  2020        PMID: 32952350      PMCID: PMC7490610          DOI: 10.6515/ACS.202009_36(5).20200516A

Source DB:  PubMed          Journal:  Acta Cardiol Sin        ISSN: 1011-6842            Impact factor:   2.672


  29 in total

Review 1.  Antithrombotic management after transcatheter aortic valve implantation.

Authors:  Fiachra McHugh; Khalid Ahmed; Antoinette Neylon; Faisal Sharif; Darren Mylotte
Journal:  J Thorac Dis       Date:  2018-11       Impact factor: 2.895

2.  Prospective comparison between three TAVR devices: ACURATE neo vs. CoreValve vs. SAPIEN XT. A single heart team experience in patients with severe aortic stenosis.

Authors:  Tannas Jatene; Antonio Castro-Filho; Rafael A Meneguz-Moreno; Dimytri A Siqueira; Alexandre A C Abizaid; Auristela I O Ramos; Magaly Arrais; David C S Le Bihan; Rodrigo B M Barretto; Adriana C Moreira; Amanda G M R Sousa; J Eduardo Sousa
Journal:  Catheter Cardiovasc Interv       Date:  2016-12-28       Impact factor: 2.692

3.  Late Coronary Obstruction After Implantation of Self-expandable Valves. Clinical and Angiographic Features of an Unexpected Complication.

Authors:  David Martí; Raquel Del Valle; Salvador Álvarez; Pablo Avanzas; Ignacio Rada; César Morís
Journal:  Rev Esp Cardiol (Engl Ed)       Date:  2017-03-02

4.  A versatile transapical device for aortic valvular disease: One-year outcomes of a multicenter study on the J-Valve system.

Authors:  Mingwui Tung; Xu Wang; Fei Li; Hao Wang; Yingqiang Guo; Chunsheng Wang; Lai Wei; Xinjin Luo; Xin Wang; Wei Wang
Journal:  J Cardiol       Date:  2018-07-29       Impact factor: 3.159

5.  The JUPITER registry: One-year outcomes of transapical aortic valve implantation using a second generation transcatheter heart valve for aortic regurgitation.

Authors:  Miriam Silaschi; Lenard Conradi; Olaf Wendler; Friederike Schlingloff; Utz Kappert; Ardawan J Rastan; Hardy Baumbach; David Holzhey; Walter Eichinger; Ralf Bader; Hendrik Treede
Journal:  Catheter Cardiovasc Interv       Date:  2017-11-24       Impact factor: 2.692

6.  Transcatheter Aortic Valve Replacement With a Repositionable Self-Expanding Prosthesis: The PORTICO-I Trial 1-Year Outcomes.

Authors:  Lars Søndergaard; Josep Rodés-Cabau; Axel Hans-Peter Linke; Stephan Fichtlscherer; Ulrich Schäfer; Karl-Heinz Kuck; Joerg Kempfert; Dabit Arzamendi; Francesco Bedogni; Federico M Asch; Stephen Worthley; Francesco Maisano
Journal:  J Am Coll Cardiol       Date:  2018-09-24       Impact factor: 24.094

7.  Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Valve Stenosis: 1-Year Results From the All-Comers NOTION Randomized Clinical Trial.

Authors:  Hans Gustav Hørsted Thyregod; Daniel Andreas Steinbrüchel; Nikolaj Ihlemann; Henrik Nissen; Bo Juel Kjeldsen; Petur Petursson; Yanping Chang; Olaf Walter Franzen; Thomas Engstrøm; Peter Clemmensen; Peter Bo Hansen; Lars Willy Andersen; Peter Skov Olsen; Lars Søndergaard
Journal:  J Am Coll Cardiol       Date:  2015-03-15       Impact factor: 24.094

8.  2017 ESC/EACTS Guidelines for the management of valvular heart disease.

Authors:  Helmut Baumgartner; Volkmar Falk; Jeroen J Bax; Michele De Bonis; Christian Hamm; Per Johan Holm; Bernard Iung; Patrizio Lancellotti; Emmanuel Lansac; Daniel Rodriguez Muñoz; Raphael Rosenhek; Johan Sjögren; Pilar Tornos Mas; Alec Vahanian; Thomas Walther; Olaf Wendler; Stephan Windecker; Jose Luis Zamorano
Journal:  Eur Heart J       Date:  2017-09-21       Impact factor: 29.983

9.  1-Year Outcomes With the Evolut R Self-Expanding Transcatheter Aortic Valve: From the International FORWARD Study.

Authors:  Ganesh Manoharan; Nicolas M Van Mieghem; Stephan Windecker; Johan Bosmans; Sabine Bleiziffer; Thomas Modine; Axel Linke; Werner Scholtz; Bernard Chevalier; Robert Gooley; Cathy Zeng; Jae K Oh; Eberhard Grube
Journal:  JACC Cardiovasc Interv       Date:  2018-11-26       Impact factor: 11.195

Review 10.  Coronary obstruction following transcatheter aortic valve implantation: a systematic review.

Authors:  Henrique Barbosa Ribeiro; Luis Nombela-Franco; Marina Urena; Michael Mok; Sergio Pasian; Daniel Doyle; Robert DeLarochellière; Mélanie Côté; Louis Laflamme; Hugo DeLarochellière; Ricardo Allende; Eric Dumont; Josep Rodés-Cabau
Journal:  JACC Cardiovasc Interv       Date:  2013-04-17       Impact factor: 11.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.